This topic contains 1 reply, has 2 voices, and was last updated by 
-
Posts
-
There are now 18 disease-modifying therapies approved for MS in the U.S. and close to that number in many other countries. Some are proving to be more effective than others, but they also carry a risk of more serious side effects. What’s your preference greater benefits and higher risk or lower benefit but less risk?
-
One week of Gilenya down…so far, so good, though I can’t say that I notice much difference other than some stomach upset (that frankly might be a lingering side effect of Solumedrol a couple of weeks ago) one way or the other.
Hoping it will pump the brakes on new lesions and give my CNS some time without disease activity to recover. We’ll see.
You must be logged in to reply to this topic.
